CPT1A and Alzheimer disease: We did not detect an association of CPT1A methylation levels with risk of all-cause or Alzheimer’s Dementia in FHS which could be due to a lack of power given the lower number of AD cases in FHS (4%) compared to ROSMAP (42%).